Is a complete MLYS research report available?

No complete published report is available for Mineralys Therapeutics, Inc. (MLYS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · USD

$26.4

-0.60 (-2.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MLYS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.3B
Net income (ttm)	-151.8M
EPS (ttm)	-$2.02
Shares out	88.2M
Volume	526,733
Beta	0.65
Price target	$49.0	+86.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -151.8M
EPS (ttm): -$2.02
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MLYS indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001933414
Company name	Mineralys Therapeutics, Inc.
Country	United States
Country code	US
Cusip	603170101
Employees	76
Employees Change	25%
Employees Change Percent	49.02
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-02-10
Isin	US6031701013
Last refreshed	2026-07-30
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$26.35
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	MLYS
Website	https://mineralystx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.53%
EV Sales Forward	628.84x
FCF yield	-5.87%
P/B ratio	3.4x
PS Forward	871.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-151.8M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	$-2M
ROA	-21.27
Roa5y	-64.6
ROCE	-26.87
ROE	-30.98
Roe5y	-356.5
ROIC	-21.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	93.84%
Cagr3y	21.94%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$652.9M
Cash	$646.1M
Current Assets	$652.5M
Current Liabilities	$14.7M
Debt	$0
Equity	$638.1M
Liabilities	$14.7M
Long Term Assets	$392,000
Long Term Liabilities	$0
Net Cash	$646.1M
Net Cash By Market Cap	$27.81
Net Cash Growth	88.34%
Net Debt Equity	$-1.01
Tangible Book Value	$638.1M
Tangible Book Value Per Share	$7.74
WACC	7.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	44.33
Net Working Capital	$-8.3M
Quick ratio	43.9
Working Capital	$637.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	93.75%
200-day SMA	31.7
3Y total return	81.35%
50-day SMA	27.02
50-day SMA vs 200-day SMA	50under200
All Time High	47.65
All Time High Change	-44.7%
All Time High Date	2025-11-12
All Time Low	5.85
All Time Low Change	350.43%
All Time Low Date	2023-11-22
ATR	1.33
Beta	0.65
Beta1y	1.73
Beta2y	1.31
Ch YTD	-27.39
High	27.37
High52	47.65
High52 Date	2025-11-12
High52ch	-44.7%
Low	26.28
Low52	12.59
Low52 Date	2025-08-13
Low52ch	109.29%
Ma50ch	-2.46%
Premarket Change Percent	0.74
Premarket Price	$27.15
Price vs 200-day SMA	-16.87%
RSI	44.04
RSI Monthly	52.98
RSI Weekly	46.2
Sharpe ratio	0.99x
Sortino ratio	2.86
Total Return	-48.35%
Tr YTD	-27.39
Tr1m	-1.24%
Tr1w	-2.44%
Tr3m	1.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	7
Analyst Price Target Top	$53
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-171.5M
Price target	$49
Price Target Change	$85.96
Price Target Change Top	$101

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66,161,930%
Float Percent	75.05%
Shares Insiders	0.6%
Shares Institutions	79.74%
Shares Out	88,158,479
Shares Qo Q	2.84%
Shares Yo Y	48.35%
Short Float	14.44%
Short Ratio	6.07
Short Shares	10.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-158.6M
Adjusted OCF	-158,627,000
Average Volume	811,054.15x
Bv Per Share	7.74
CAPEX	$-15,000
Ch1m	-1.24
Ch1w	-2.44
Ch1y	93.75
Ch3m	1.78
Ch3y	81.35
Ch6m	-18.52
Change	-2.23%
Change From Open	-2.41
Close	26.95
Days Gap	0.19
Depreciation Amortization	50,000
Dollar Volume	13,879,414.6
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-171.5M
EBITDA	$-171.4M
EPS	$-2.02
F Score	2
FCF	$-136.4M
FCF EV Yield	-8.13x
FCF Per Share	$-1.55
Financing CF	425,992,000
Fiscal Year End	December
Founded	2,019
Investing CF	-341,820,000
Ipr	64.69
Iprfo	24.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	28.68
Ma150ch	-8.12%
Ma20	27.69
Ma20ch	-4.82%
Net CF	-52,228,000
Next Earnings Date	2026-08-11
Open	27
Optionable	Yes
Position In Range	6.42
Post Close	26.35
Postmarket Change Percent	-4.6
Postmarket Price	$25.14
Ppne	32,000
Pre Close	26.95
Price Date	2026-07-29
Ptbv Ratio	3.64
Relative Volume	0.65x
Share Based Comp	22,227,000
Tr6m	-18.52%
Us State	Pennsylvania
Volume	526,733

Mineralys Therapeutics, Inc. (MLYS)

Coverage state: Market snapshot only — no published research

Generate the first MLYS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MLYS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MLYS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MLYS

Frequently asked questions